3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
130
Brain Neoplasms
115
Prostatic Neoplasms
101
Neoplasm Metastasis
83
Lung Neoplasms
72
Carcinoma, Hepatocellular
71
Pancreatic Neoplasms
67
Breast Neoplasms
48
Melanoma
44
Carcinoma, Renal Cell
36
Neoplasms
33
Colorectal Neoplasms
26
Squamous Cell Carcinoma of Head and Neck
25
Glioblastoma
24
Liver Neoplasms
20
Head and Neck Neoplasms
16
Small Cell Lung Carcinoma
15
Sarcoma
13
Glioma
12
Kidney Neoplasms
11
Urinary Bladder Neoplasms
9
Recurrence
9
Gliosarcoma
8
Ovarian Neoplasms
7
Adenocarcinoma of Lung
7
Adenocarcinoma
7
Prostate Cancer Metastatic
6
Cholangiocarcinoma
6
Central Nervous System Neoplasms
6
Uveal Melanoma
5
Interventions
Carboplatin
19
Pemetrexed
10
Paclitaxel
7
pembrolizumab
5
Nivolumab
5
Cisplatin
5
Gemcitabine
4
osimertinib
3
entinostat
3
camrelizumab
3
atezolizumab
3
Erlotinib Hydrochloride
3
zipalertinib
2
selpercatinib
2
pralsetinib
2
durvalumab
2
apatinib
2
Vinorelbine
2
Surveys and Questionnaires
2
One-Lung Ventilation
2
Ipilimumab
2
Docetaxel
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
toripalimab
1
spartalizumab
1
sotorasib
1
sitravatinib
1
sintilimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lung Diseases
×
Radiosurgery
×
Clear all
NCT02984761
2026-02-19
VALOR
VA Office of Research and Development
Phase NA
Recruiting
670 enrolled